Once weekly administration of etanercept 50mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension

BackgroundIn previous studies, etanercept 25mg twice weekly (BIW) or 50mg BIW significantly reduced disease severity in patients with plaque psoriasis and demonstrated a favourable safety profile. ObjectivesTo assess the efficacy and safety of etanercept 50mg administered once weekly (QW) compared w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of dermatology (1951) 2008-11, Vol.159 (5), p.1177-1185
Hauptverfasser: van de Kerkhof, PCM, Segaert, S, Lahfa, M, Luger, T A, Karolyi, Z, Kaszuba, A, Leigheb, G, Camacho, F M, sea, D, Zang, C, Boussuge, M P, Paolozzi, L, Wajdula, J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!